UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long-term disease control in a patient with ALK-positive non-small cell lung cancer

Medicinskij sovet, 2022-06 (9), p.172-177

2022

Volltextzugriff (PDF)

Five-year results of nivolumab for the treatment of non-small cell lung cancer in clinical practice of the N.N. Blokhin Russian Cancer Research Center

Medicinskij sovet, 2021-08 (9), p.18-24

2021

Volltextzugriff (PDF)

Prospects for the development of adjuvant therapy for non-small cell lung cancer

Sovremennaia onkologiia : zhurnal kafedry onkologii RMAPO dlia nepreryvnogo poslediplomnogo obrazovaniia, 2020-11, Vol.22 (3), p.85-87

2020

Volltextzugriff (PDF)

Rational approach to the treatment of EGFR-positive lung cancer

Medicinskij sovet, 2019-12 (19), p.51-56

2019

Volltextzugriff (PDF)

Conservative treatment of stage III lung cancer using chemoradiotherapy in hypofractionation mode, case report

Medicinskij sovet, 2020-07 (9), p.271-276

2020

Volltextzugriff (PDF)

A case report of immune-related pneumonitis after combined treatment of non small cell lung cancer

Medicinskij sovet, 2020-07 (9), p.258-264

2020

Volltextzugriff (PDF)

Will neo-adjuvant immunotherapy become a new paradigm in the treatment of lung cancer patients

Medicinskij sovet, 2019-12 (19), p.22-29

2019

Volltextzugriff (PDF)

Combined chemoradiotherapy regimens and their effectiveness in the treatment of patients with non-small-cell unresectable stage III lung cancer: review of literature

Medicinskij sovet, 2019-06 (10), p.92-98

2019

Volltextzugriff (PDF)

Pseudoprogression in patients on immunotherapy

Medicinskij sovet, 2019-06 (10), p.10-14

2019

Volltextzugriff (PDF)

A preliminary results of integrated chemotherapy with EGFR receptor tyrosine kinase inhibitors in patients with non-small-cell-lung cancer harboring EGFR mutation

Medicinskij sovet, 2019-06 (10), p.110-114

2019

Volltextzugriff (PDF)

TARGETED THERAPY OF LUNG CANCER WITH THE ROS1 REARRANGEMENT

Medical Council, 2017-06 (6), p.51-55

2017

Volltextzugriff (PDF)

Intermediate results of combination therapy in patients with oligometastatic non-small cell lung cancer

Medical Council, 2018-11 (19), p.122-125

2018

Volltextzugriff (PDF)

New possibilities in the treatment of EGFR mutation-positive non-small-cell lung cancer patients after the progression on a 1st and 2nd generation EGFR tyrosine kinase inhibitors

Sovremennaia onkologiia : zhurnal kafedry onkologii RMAPO dlia nepreryvnogo poslediplomnogo obrazovaniia, 2018-06, Vol.20 (2), p.50-54

2018

Volltextzugriff (PDF)

THE FIRST CLINICAL EXPERIENCE WITH AFATINIB IN RUSSIAN FEDERATION

Medical Council, 2016-12 (10), p.66-72

2016

Volltextzugriff (PDF)

Efficiency integrated chemotherapy with EGFR receptor tyrosine kinase inhibitors in patients with non-small cell lung cancer and an activating EGFR gene mutation

Voprosy onkologij, 2021-04, Vol.67 (2), p.246-253

2021

Volltextzugriff (PDF)

TARGETED THERAPY OF NON-SMALL-CELL LUNG CANCER PATIENTS: MOST COMMON ADVERSE EVENTS AND METHODS OF THEIR CORRECTIONS

Rossiĭskiĭ onkologicheskiĭ zhurnal = Russian journal of oncology, 2017-12, Vol.22 (6), p.300-306

2017

Volltextzugriff (PDF)

First results of durvalumab after chemoradiotherapy in locally advanced non-small-cell lung cancer in Russia

Medicinskij sovet, 2022-12 (22), p.12-20

2022

Volltextzugriff (PDF)

Significance of the expression of nucleolar argyrophilic proteins and antigen Ki-67 in the evaluation of cell proliferative activity and in the prediction of minimal (T1) lung cancer

Arkhiv patologii, 2008-05, Vol.70 (3), p.15

2008

Volltextzugriff (PDF)

Rebiopsy in IV stage non-small-cell lung cancer patients after systemic therapy

Rossiĭskiĭ onkologicheskiĭ zhurnal = Russian journal of oncology, 2016-08, Vol.21 (4), p.179-185

2016

Volltextzugriff (PDF)

HIGH-TECH RADIATION THERAPY WITH LOCAL DOSE ESCALATION IN CHEMO-RADIATION TREATMENT OF PATIENTS WITH LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER. PREDICTORS OF EFFECTIVENESS

Voprosy onkologij, 2018-06, Vol.64 (6), p.774-781

2018

Volltextzugriff (PDF)

Immune-related encephalopathy at nivolumab effective treatment of lung adenocarcinoma. A case report

Malignant tumours, 2018-05, Vol.8 (1), p.71-76

2018

Volltextzugriff (PDF)

Ceritinib as a long-term disease control: Clinical observation

Medicinskij sovet, 2024-07 (10), p.60-65

2024

Volltextzugriff (PDF)

Adjuvant immunotherapy of operable non-small cell lung cancer: achievements and treatment prospects

Medicinskij sovet, 2022-06 (9), p.14-20

2022

Volltextzugriff (PDF)

Lung cancer associated with an activating mutation in the 14th exon of the MET gene

Medicinskij sovet, 2024-07 (10), p.153-160

2024

Volltextzugriff (PDF)

Clinical case of long-term disease control in a patient with EGFR-positive non-small cell lung cancer

Medicinskij sovet, 2022-12 (22), p.154-159

2022

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(1)

Publikationsform

Artikel
(25)
Bücher
(1)

Sprache

Englisch
(24)
Russisch
(12)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Long-term disease control in a patient with ALK-positive non-small cell lung cancer

Five-year results of nivolumab for the treatment of non-small cell lung cancer in clinical practice of the N.N. Blokhin Russian Cancer Research Center

Prospects for the development of adjuvant therapy for non-small cell lung cancer

Rational approach to the treatment of EGFR-positive lung cancer

Conservative treatment of stage III lung cancer using chemoradiotherapy in hypofractionation mode, case report

A case report of immune-related pneumonitis after combined treatment of non small cell lung cancer

Will neo-adjuvant immunotherapy become a new paradigm in the treatment of lung cancer patients

Combined chemoradiotherapy regimens and their effectiveness in the treatment of patients with non-small-cell unresectable stage III lung cancer: review of literature

Pseudoprogression in patients on immunotherapy

A preliminary results of integrated chemotherapy with EGFR receptor tyrosine kinase inhibitors in patients with non-small-cell-lung cancer harboring EGFR mutation

TARGETED THERAPY OF LUNG CANCER WITH THE ROS1 REARRANGEMENT

Intermediate results of combination therapy in patients with oligometastatic non-small cell lung cancer

New possibilities in the treatment of EGFR mutation-positive non-small-cell lung cancer patients after the progression on a 1st and 2nd generation EGFR tyrosine kinase inhibitors

THE FIRST CLINICAL EXPERIENCE WITH AFATINIB IN RUSSIAN FEDERATION

Efficiency integrated chemotherapy with EGFR receptor tyrosine kinase inhibitors in patients with non-small cell lung cancer and an activating EGFR gene mutation

TARGETED THERAPY OF NON-SMALL-CELL LUNG CANCER PATIENTS: MOST COMMON ADVERSE EVENTS AND METHODS OF THEIR CORRECTIONS

First results of durvalumab after chemoradiotherapy in locally advanced non-small-cell lung cancer in Russia

Significance of the expression of nucleolar argyrophilic proteins and antigen Ki-67 in the evaluation of cell proliferative activity and in the prediction of minimal (T1) lung cancer

Rebiopsy in IV stage non-small-cell lung cancer patients after systemic therapy

HIGH-TECH RADIATION THERAPY WITH LOCAL DOSE ESCALATION IN CHEMO-RADIATION TREATMENT OF PATIENTS WITH LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER. PREDICTORS OF EFFECTIVENESS

Immune-related encephalopathy at nivolumab effective treatment of lung adenocarcinoma. A case report

Ceritinib as a long-term disease control: Clinical observation

Adjuvant immunotherapy of operable non-small cell lung cancer: achievements and treatment prospects

Lung cancer associated with an activating mutation in the 14th exon of the MET gene

Clinical case of long-term disease control in a patient with EGFR-positive non-small cell lung cancer

Suchergebnisse filtern